Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Cancer Research Communications|February 2, 2026
ANGPTL3 in the peripheral circulation is associated with resistance to anti-PD1 therapy in advanced gastric cancerChie Kudo-Saito, Hirokazu Shoji, Kengo Nagashima, et al.Cancer Immunology, Immunotherapy : CII|November 18, 2025
The FSTL1-DIP2A axis is a significant biomarker for predicting anti-PD1 therapeutic efficacy in advanced gastric cancerChie Kudo-Saito, Hiroshi Imazeki, Kengo Nagashima, et al.Discover Oncology|October 22, 2025
Peripheral SNCA+ cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancerChie Kudo-Saito, Hiroshi Imazeki, Kengo Nagashima, et al.Journal for Immunotherapy of Cancer|November 3, 2024
Myeloid subsets impede the efficacy of anti-PD1 therapy in patients with advanced gastric cancer (WJOG10417GTR study)Hirokazu Shoji, Chie Kudo-Saito, Kengo Nagashima, et al.Journal of Translational Medicine|October 17, 2025
IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancerChie Kudo-Saito, Hiroshi Imazeki, Kengo Nagashima, et al.Annals of the New York Academy of Sciences|May 9, 2013
Cancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapyYutaka Kawakami, Tomonori Yaguchi, Hidetoshi Sumimoto, et al.European Journal of Cancer (Oxford, England : 1990)|September 27, 2017
Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinomaTomonari Kinoshita, Chie Kudo-Saito, Reiko Muramatsu, et al.Pageof 5